OXA-535 is a chromosome-encoded carbapenemase of Shewanella bicestrii JAB-1 that shares only 91.3% amino acid sequence identity with OXA-48. Catalytic efficiencies are similar to those of OXA-48 for most β-lactams, except for ertapenem, where a 2,000-fold-higher efficiency was observed with OXA-535.
KEYWORDS: OXA-48-like, carbapenemase, progenitor, OXA-48, Shewanella
ABSTRACT
OXA-535 is a chromosome-encoded carbapenemase of Shewanella bicestrii JAB-1 that shares only 91.3% amino acid sequence identity with OXA-48. Catalytic efficiencies are similar to those of OXA-48 for most β-lactams, except for ertapenem, where a 2,000-fold-higher efficiency was observed with OXA-535. OXA-535 and OXA-436, a plasmid-encoded variant of OXA-535 differing by three amino acids, form a novel cluster of distantly related OXA-48-like carbapenemases. Comparison of blaOXA-535 and blaOXA-436 genetic environments suggests that an ISCR1 may be responsible for blaOXA-436 gene mobilization from the chromosome of Shewanella spp. to plasmids.
TEXT
OXA-48, a carbapenemase, has become a major public health threat because of its rapid spread worldwide (1–3). Along with this rapid dispersion, several OXA-48 variants have been reported (4–6). For a complete list of variants, see the β-lactamase database (http://bldb.eu/BLDB.php?class=D#OXA) (4). Analysis of the genetic context of blaOXA-48-like genes in Enterobacteriaceae has shown their association with insertion sequences (IS1999, ISEcp1, and IS4321) and with various plasmids (7–10). Shewanella spp. constitute the reservoir of blaOXA-48-like genes. So far, the gene variants blaOXA-48, blaOXA-199, blaOXA-204, and blaOXA-416 genes have been reported in Shewanella xiamenensis, although some researchers have identified blaOXA-48-like genes in other Shewanella spp. (11–17). OXA-535, the naturally occurring oxacillinase of Shewanella bicestrii JAB-1, share only 91.3% and 98.9% amino acid sequence identities with OXA-48 and the plasmid-borne OXA-436, respectively (5, 18) (Fig. 1A). The aim of this study was to characterize the biochemical properties of OXA-535 and investigate its genetic environment in S. bicestrii JAB-1.
FIG 1.
Amino acid sequence alignment of different OXA-48-like variants and molecular modeling. (A) Dashes indicate identical residues among all the amino acid sequences. Amino acid motifs that are well conserved among class D β-lactamases are indicated by gray boxes, and the single black-outlined box corresponds to the β5-β6 loop. Numbering is according to DBL (1). OXA sequences were from the β-lactamase database (http://bldb.eu/BLDB.php?class=D#OXA) (4) and ANA-3_OXA-48-like, MR-7_OXA-48-like, MR-4_OXA-48-like, and Shew256_OXA-48-like were from GenBank (accession nos. WP_011718232.1, WP_011627184.1, WP_011621491.1, and WP_088210206.1, respectively). (B) Superposition of crystal structures of OXA-535 (gray) and OXA-48 (red; PDB accession no. 4S2P). Residues Ser70 and Lys73 are shown in a Corey-Pauling-Koltun (CPK) representation and shown in yellow and blue, respectively. (C) Covalent docking pose of ertapenem (green, stick representation) in the binding site of OXA-535 (gray, surface representation). Residues Ala104, Arg107, and Tyr185 are orange, cyan, and magenta, respectively. Images were generated using Chimera (23). (D) Highlight of the favorable interaction between ertapenem (covalent docking pose) and residues Ala104, Arg107, and Tyr185 of OXA-535. (E) Highlight of the sterical hindrance between ertapenem and the Thr104 residue of OXA-48 superimposed on the OXA-535 structure.
MIC values were determined as previously described (18). Escherichia coli TOP10 (Invitrogen, Saint-Aubin, France) expressing OXA-535 from the pTOPO plasmid was resistant to penicillins, including temocillin, and reduced susceptibility to carbapenems; whereas the expanded-spectrum cephalosporins remained in the susceptibility range, in a manner similar to that of E. coli TOP10 expressing OXA-48 from a pTOPO plasmid (6, 18) (Table 1).
TABLE 1.
MIC of β-lactams for Shewanella spp. JAB-1 and E. coli TOP10 pTOPO-OXA-535, TOP10 pTOPO-OXA-48, and TOP10
| Antibiotic | MIC (mg/liter) |
|||
|---|---|---|---|---|
| Shewanella sp. JAB-1 |
E. coli TOP10 |
E. coli TOP10 | ||
| pTOPO-OXA-535 | pTOPO-OXA-48 | |||
| Amoxicillin | >256 | >256 | >256 | 2 |
| Amoxicillin + CLAa | 8 | 128 | >256 | 2 |
| Piperacillin | >256 | >256 | >256 | 1.5 |
| Temocillinb | 0.25 | >1,024 | >1,024 | 4 |
| Cefotaximeb | >32 | 0.06 | 0.75 | 0.06 |
| Ceftazidimeb | 2 | 0.19 | 0.19 | 0.12 |
| Cefepime | 8 | 0.023 | 0.19 | 0.023 |
| Imipenemb | 0.38 | 1 | 0.75 | 0.25 |
| Ertapenemb | 1 | 0.25 | 0.25 | 0.003 |
| Meropenemb | 0.38 | 0.19 | 0.25 | 0.016 |
CLA, clavulanic acid (2 mg/liter).
MIC data for these antibiotics were retested in this work but are similar to those presented by Jousset et al. (18).
A DNA fragment corresponding to the mature OXA-535, generated with the primers INF-OXA-48Fw (5′-AAGGAGATATACATATGGTAGCAAAGGAATGGCAAG-3′) and INF-OXA-48Rv (5′-GGTGGTGGTGCTCGAAGGGAATAATTTTTTCCTGTTTGAG-3′), was cloned into the expression vector pET41b (+) (Novagen, VWR International, Fontenay-sous-Bois, France), and recombinant plasmid pET41-OXA-535 was electroporated into the electrocompetent E. coli strain BL21(DE3) (Novagen). OXA-535 was overexpressed and purified, and steady-state kinetic parameters were determined and compared with those of OXA-48 as previously described (6, 19).
Initial hydrolysis tests using pure undiluted OXA-535 revealed an absence of hydrolysis of penicillins (ampicillin, oxacillin, piperacillin, amoxicillin, and benzylpenicillin), whereas the other β-lactams tested were rapidly hydrolyzed by OXA-535 in a manner similar to that of OXA-48 (Table 2). The addition of 50 mM sodium hydrogen carbonate (NaHCO3) as a source of CO2 did not modify the rates of penicillin hydrolysis, suggesting that the absence of penicillinase activity with concentrated OXA-535 may not be due to Lys73 decarboxylation (20). When using 100-fold-diluted OXA-535 preparations, penicillin hydrolysis was restored in a manner similar to that of OXA-48. This peculiar behavior of OXA-535 in respect to penicillin hydrolysis may be the result of two mechanisms: (i) an alteration in the affinity of the enzyme for penicillins at high enzymatic concentrations and/or (ii) a modification in the hydrolysis mechanism that may involve an alternative catalytic process specific for penicillins, active only with low concentrations of the enzyme, which may be a result of enzyme concentration-dependent conformational changes. Structural analyses should be performed to explain this peculiar OXA-535 behavior.
TABLE 2.
Comparison of the steady-state kinetic parameters of OXA-48 and OXA-535 β-lactamases
| Substrate |
Km (μM) |
kcat (s−1) |
kcat/Km (mM−1/s−1) |
|||
|---|---|---|---|---|---|---|
| OXA-48 | OXA-535 | OXA-48 | OXA-535 | OXA-48 | OXA-535 | |
| Ampicillin | 395 | 67 | 955 | 41 | 2,418 | 615 |
| Oxacillin | 95 | 53 | 130 | 64 | 1,368 | 1,210 |
| Temocillin | 45 | 357 | 0.30 | 1.8 | 6.6 | 5.1 |
| Cefalotin | 195 | 197 | 44 | 15 | 226 | 74 |
| Cefoxitin | >200 | 268 | >0.05 | 0.07 | 0.26 | 0.27 |
| Ceftazidime | NHa | >1,000 | NH | >0.01 | NH | 0.01 |
| Cefotaxime | >900 | >1,000 | >9.0 | >3.9 | 10 | 3.9 |
| Cefepime | >550 | >1,000 | >0.60 | >0.34 | 1.1 | 0.34 |
| Imipenem | 13 | 105 | 4.8 | 7.1 | 369 | 67 |
| Meropenem | 11 | 3.0 | 0.07 | 0.20 | 6.2 | 68 |
| Ertapenem | 100 | 0.06 | 0.13 | 0.17 | 1.3 | 2,646 |
NH, hydrolysis was not detected with concentrations of substrate and enzymes up to 1,000 and 400 nM, respectively.
Steady-state kinetic parameters for penicillins were determined by using diluted OXA-535 preparations. OXA-535 and OXA-48 presented similar catalytic efficiencies for oxacillin and temocillin (Table 2) (6). Compared with OXA-48, OXA-535 catalytic efficiency was (i) ∼4-fold lower for ampicillin due to a lower turnover number; (ii) 3-fold lower for cephalothin due to a lower kcat; (iii) 5-fold lower for imipenem as a result of a lower affinity (8-fold increased km); (iv) 11-fold higher for meropenem as a result of better affinity and turnover values; and, most surprisingly, (v) ∼1,800-fold higher for ertapenem, because of a 1,660-fold-higher affinity, with similar velocity of hydrolysis to that of OXA-48 (Table 2). This reduced activity against imipenem of OXA-535 may explain the negative results observed by Jousset et al. (18), who used Carba NP tests. The fact that OXA-535-like enzymes are difficult to detect with biochemical tests, such as Carba NP, may lead to the silent spread of this type of enzyme, in a manner similar to that of OXA-244 (18, 21).
Suitable conditions for the crystallization of OXA-535 were found at facilities of the Institute for Integrative Biology of the Cell (I2BC, Gif-sur-Yvette, France), and the resulting crystals were used for acquisition of X-ray diffraction data at the SOLEIL synchrotron (Saclay, France). A preliminary crystallographic study (data not shown) showed that the structures of OXA-535 and OXA-48 are very similar, with the exception of three regions situated relatively far from the binding site, i.e., 49 to 55, 94 to 106, and 252 to 261 (class D β-lactamase [DBL] numbering system) (Fig. 1B) (1). Covalent docking of ertapenem using GOLD and the GoldScore scoring function showed a strong ionic interaction between the terminal carboxylate group of the ligand and the side chain of Arg107 and a C-H…π interaction between the side chain of Tyr185 and the terminal aromatic group of ertapenem (Fig. 1C) (22). Comparison with the OXA-48 structure showed that the residue in position 104 plays a key role in ertapenem binding, thus explaining the huge difference in affinity between OXA-48 and OXA-535 determined for this substrate. Indeed, Ala104 in OXA-535 is compatible with ertapenem binding, given the small size of the side chain and the modified conformation of loop 94 to106 (Fig. 1D), whereas Thr104 in OXA-48 is bulkier and completely blocks ertapenem binding in this region (Fig. 1E). These differences may have led to the observed 1,800-fold difference in catalytic efficiency.
Upstream of the blaOXA-535 gene, we identified sprT and endA genes encoding an SprT-like protein of unknown function and endonuclease I, respectively. The same genetic organization was described for closely related chromosomally encoded blaOXA-48-like genes, such as the blaOXA-48-like-MR-4 gene (Fig. 2). The downstream sequence of the blaOXA-535 gene is commonly present downstream of blaOXA-48-like genes on the chromosomes of Shewanella spp. (11, 12). The 2,394-bp upstream and 4,074-bp downstream sequences of the blaOXA-535 gene were identical to those of blaOXA-436, further supporting that the chromosomally encoded blaOXA-535 gene may be the progenitor of the plasmid-encoded blaOXA-436 gene (5). An ISCR1 element found upstream of the blaOXA-436 gene but absent upstream of the blaOXA-535 gene may be responsible for the blaOXA-535-like gene mobilization from the chromosome of Shewanella spp. to plasmids (Fig. 2). ISCR1 carries a single orf that is responsible for a rolling-circle type of transposition mechanism (24). Flanking gene acquisition is thought to occur when the termination mechanism fails and rolling-circle replication extends into neighboring DNA, where it may encounter a second surrogate end (24). In the case of the blaOXA-436 gene, the DNA sequence putatively mobilized by ISCR1-mediated rolling-circle transposition corresponded to an ∼6.5-kb fragment present also in S. bicestrii JAB-1 and surrounding the blaOXA-535 gene. Our findings illustrate the increasing complexity of genetic vehicles at the origin of OXA-48-type carbapenemase spread (7–10). The finding of ISCR1 upstream of blaOXA-48-like genes is worrisome, because this ISCR1plays an important role in the assembly and transmission of multiple antibiotic resistance genes (5, 18, 24).
FIG 2.
Genetic contexts of the blaOXA-535 gene. Major genetic features of the environment of the different blaOXA-48-like genes in Shewanella spp., i.e., MR-4 (accession no. CP000446.1) and S. bicestrii JAB-1 (accession no. NZ_CP022358.1), and of plasmid pOXA-436 (accession no. KY863418.1) isolated from Enterobacter asburiae strain AMA 497. Common features are highlighted in gray. sprT codes for a SprT-like protein of unknown function, endA encodes an endonuclease I, lysR encodes a putative lysR-type transcriptional regulator gene, and cps encodes a carbamoyl-phosphate synthase.
ACKNOWLEDGMENTS
We acknowledge SOLEIL for provision of synchrotron radiation facilities (proposal ID BAG20160782) for use of Proxima beamlines.
This work was supported by Assistance Publique—Hôpitaux de Paris, Université Paris Sud, the Laboratory of Excellence in Research on Medication and Innovative Therapeutics (LERMIT), by a grant from the French National Research Agency (ANR-10-LABX-33), and by DIM Malinf, Ile de France.
We have no competing interests to declare.
REFERENCES
- 1.Poirel P, Naas T, Nordmann. 2010. Diversity, epidemiology, and genetics of class D β-lactamases. Antimicrob Agents Chemother 54:24–38. doi: 10.1128/AAC.01512-08. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Van Duin D, Doi Y. 2017. The global epidemiology of carbapenemase-producing Enterobacteriaceae. Virulence 8:460-469. doi: 10.1080/21505594.2016.1222343. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Poirel L, Heritier C, Tolun V, Nordmann P. 2004. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother 48:15–22. doi: 10.1128/AAC.48.1.15-22.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Naas T, Oueslati S, Bonnin RA, Dabos ML, Zavala A, Dortet L, Retailleau P, Iorga BI. 2017. Beta-lactamase database (BLDB)—structure and function. J Enzyme Inhib Med Chem 32:917–919. doi: 10.1080/14756366.2017.1344235. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Samuelsen Ø, Hansen F, Aasnæs B, Hasman H, Lund BA, Leiros HS, Lilje B, Janice J, Jakobsen L, Littauer P, Søes LM, Holzknecht BJ, Andersen LP, Stegger M, Andersen PS, Hammerum AM. 2018. Dissemination and characteristics of a novel plasmid-encoded carbapenem-hydrolyzing class D β-lactamase, OXA-436, found in isolates from four patients at six different hospitals in Denmark. Antimicrob Agents Chemother 62:e01260-17. doi: 10.1128/AAC.01260-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Oueslati S, Nordmann P, Poirel L. 2015. Heterogeneous hydrolytic features for OXA-48-like β-lactamases. J Antimicrob Chemother 70:1059–1063. [DOI] [PubMed] [Google Scholar]
- 7.Aubert D, Naas T, Heritier C, Poirel L, Nordmann P. 2006. Functional characterization of IS1999, an IS4 family element involved in mobilization and expression of β-lactam resistance genes. J Bacteriol 188:6506–6514. doi: 10.1128/JB.00375-06. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Poirel L, Bonnin RA, Nordmann P. 2012. Genetic features of the widespread plasmid coding for the carbapenemase OXA-48. Antimicrob Agents Chemother 56:559–562. doi: 10.1128/AAC.05289-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9.Sidjabat HE, Kennedy K, Silvey A, Collignon P, Paterson D. 2013. Emergence of blaOXA-181-carrying ColE plasmid in Klebsiella pneumoniae in Australia. Int J Antimicrob Agents 41:294–296. doi: 10.1016/j.ijantimicag.2012.11.003. [DOI] [PubMed] [Google Scholar]
- 10.Poirel L, Castanheira M, Carrer A, Rodriguez CP, Jones RN, Smayevsky J, Nordmann P. 2011. OXA-163, an OXA-48-related class D β-lactamase with extended activity toward expanded-spectrum cephalosporins. Antimicrob Agents Chemother 55:2546–2551. doi: 10.1128/AAC.00022-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Poirel L, Heritier C, Nordmann P. 2004. Chromosome-encoded ambler class D β-lactamase of Shewanella oneidensis as a progenitor of carbapenem-hydrolyzing oxacillinase. Antimicrob Agents Chemother 48:348–351. doi: 10.1128/AAC.48.1.348-351.2004. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Tacão M, Araújo S, Vendas M, Alves A, Henriques I. 2018. Shewanella species as the origin of blaOXA-48 genes: insights into gene diversity, associated phenotypes and possible transfer mechanisms. Int J Antimicrob Agents 51:340–348. doi: 10.1016/j.ijantimicag.2017.05.014. [DOI] [PubMed] [Google Scholar]
- 13.Zong Z. 2012. Discovery of blaOXA-199 a chromosome-based blaOXA-48-like variant in Shewanella xiamenensis. PLoS One 7:e48280. doi: 10.1371/journal.pone.0048280. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Antonelli A, Di Palo DM, Galano A, Becciani S, Montagnani C, Pecile P, Galli L, Rossolini GM. 2015. Intestinal carriage of Shewanella xiamenensis simulating carriage of OXA-48-producing Enterobacteriaceae. Diagn Microbiol Infect Dis 82:1–3. doi: 10.1016/j.diagmicrobio.2015.02.008. [DOI] [PubMed] [Google Scholar]
- 15.Potron A, Poirel L, Nordmann P. 2011. Origin of OXA-181, an emerging carbapenem-hydrolyzing oxacillinase, as a chromosomal gene in Shewanella xiamenensis. Antimicrob Agents Chemother 55:4405–4407. doi: 10.1128/AAC.00681-11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Tacão M, Correia A, Henriques I. 2013. Environmental Shewanella xiamenensis strains that carry blaOXA-48 or blaOXA-204 genes: additional proof for blaOXA-48-like gene origin. Antimicrob Agents Chemother 57:6399–6400. doi: 10.1128/AAC.00771-13. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Kim DM, Kang CI, Lee CS, Kim HB, Kim EC, Kim NJ, Oh MD, Choe KW. 2006. Treatment failure due to emergence of resistance to carbapenem during therapy for Shewanella algae bacteremia. J Clin Microbiol 44:1172–1174. doi: 10.1128/JCM.44.3.1172-1174.2006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Jousset AB, Dabos L, Bonnin RA, Girlich D, Potron A, Cabanel N, Dortet L, Glaser P, Naas T. 2018. CTX-M-15-producing Shewanella sp. clinical isolate expressing OXA-535, a chromosome-encoded OXA-48 variant, putative progenitor of the plasmid-encoded OXA-436. Antimicrob Agents Chemother 62:e01879-17. doi: 10.1128/AAC.01879-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Dabos L, Bogaerts P, Bonnin RA, Zavala A, Sacré P, Iorga BI, Huang DT, Glupczynski Y, Naas T. 2018. Genetic and biochemical characterization of OXA-519, a novel OXA-48-like β-lactamase. Antimicrob Agents Chemother 62:e00469-18. doi: 10.1128/AAC.00469-18. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Meziane-Cherif D, Bonnet R, Haouz A, Courvalin P. 2016. Structural insights into the loss of penicillinase and the gain of ceftazidimase activities by OXA-145 β-lactamase in Pseudomonas aeruginosa. J Antimicrob Chemother 71:395–402. doi: 10.1093/jac/dkv375. [DOI] [PubMed] [Google Scholar]
- 21.Hoyos-Mallecot Y, Naas T, Bonnin RA, Patino R, Glaser P, Fortineau N, Laurent Dortet L. 2017. OXA-244-producing Escherichia coli isolates, a challenge for clinical microbiology laboratories. Antimicrob Agents Chemother 61:e00818-17. doi: 10.1128/AAC.00818-17. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Verdonk ML, Cole JC, Hartshorn MJ, Murray CW, Taylor RD. 2003. Improved protein-ligand docking using GOLD. Proteins 52:609–623. doi: 10.1002/prot.10465. [DOI] [PubMed] [Google Scholar]
- 23.Pettersen EF, Goddard TD, Huang CC, Couch GS, Greenblatt DM, Meng EC, Ferrin TE. 2014. UCSF Chimera—a visualization system for exploratory research and analysis. J Comput Chem 25:1605–1612. [DOI] [PubMed] [Google Scholar]
- 24.Toleman MA, Walsh TR. 2011. Combinatorial events of insertion sequences and ICE in Gram-negative bacteria. FEMS Microbiol Rev 35:912–935. doi: 10.1111/j.1574-6976.2011.00294.x. [DOI] [PubMed] [Google Scholar]


